Skip to content
10-Q

Quarterly Report

PHARMOS CORP

0001513160-12-000088

← back to feed
Filed
Nov 19, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · Nov 19, 2012 60.17M sh
Operating Cash Flow Q3 2012 · Sep 30, 2012 −$1.26M
Operating Cash Flow Q3 2012 · Sep 30, 2011 −$1.34M
Cash And Equivalents Q3 2012 · Sep 30, 2012 $279.37K
Cash And Equivalents Q3 2012 · Dec 31, 2011 $1.54M
Cash And Equivalents Q3 2012 · Sep 30, 2011 $1.8M
Cash And Equivalents Q3 2012 · Dec 31, 2010 $3.14M
Stockholders Equity Q3 2012 · Sep 30, 2012 −$784.77K
Stockholders Equity Q3 2012 · Dec 31, 2011 $301.15K
Current Liabilities Q3 2012 · Sep 30, 2012 $1.12M
Current Liabilities Q3 2012 · Dec 31, 2011 $1.36M
Total Liabilities Q3 2012 · Sep 30, 2012 $1.12M
Total Liabilities Q3 2012 · Dec 31, 2011 $1.36M
Current Assets Q3 2012 · Sep 30, 2012 $330.62K
Current Assets Q3 2012 · Dec 31, 2011 $1.66M
Total Assets Q3 2012 · Sep 30, 2012 $333.27K
Total Assets Q3 2012 · Dec 31, 2011 $1.66M
Sga Expense Q3 2012 · Sep 30, 2012 $243.17K
Sga Expense Q3 2012 · Sep 30, 2012 $740.98K
Sga Expense Q3 2012 · Sep 30, 2011 $244.6K
Sga Expense Q3 2012 · Sep 30, 2011 $798.36K
Rd Expense Q3 2012 · Sep 30, 2012 $62.71K
Rd Expense Q3 2012 · Sep 30, 2012 $468.23K
Rd Expense Q3 2012 · Sep 30, 2011 $175.35K
Rd Expense Q3 2012 · Sep 30, 2011 $671.6K
Net Income Q3 2012 · Sep 30, 2012 −$331.48K
Net Income Q3 2012 · Sep 30, 2012 −$1.29M
Net Income Q3 2012 · Sep 30, 2011 −$446.04K
Net Income Q3 2012 · Sep 30, 2011 −$1.55M
Operating Income Q3 2012 · Sep 30, 2012 −$306.5K
Operating Income Q3 2012 · Sep 30, 2012 −$1.21M
Operating Income Q3 2012 · Sep 30, 2011 −$420.71K
Operating Income Q3 2012 · Sep 30, 2011 −$1.47M
Capex Q3 2012 · Sep 30, 2011 $1.6K